Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma

Northwest Biotherapeutics United Kingdom Maryland

                                                                                          

Les Goldman
240-234-0059
[e-mail]

Logo - https://mma.prnewswire.com/media/325355/northwest_biotherapeutics__inc__logo.jpg  

View original content:https://www.prnewswire.co.uk/news-releases/northwest-biotherapeutics-announces-that-a-marketing-authorization-application-has-been-submitted-to-the-uk-mhra-for-dcvax-l-for-glioblastoma-302021042.html